AUCextrap more than 20% [Study As­sess­ment]

posted by Helmut Homepage – Vienna, Austria, 2013-08-01 14:32 (4710 d 21:35 ago) – Posting: # 11144
Views: 31,501

Hi Sam,

❝ […] ER formulation for USFDA. The results are very good for the Cmax and AUCinf but the study fails marginally in lower CI in AUCt that is 79.28. The failure in this study is due to the presence of two outlier in the whole study. If we remove these outliers the study qualify the BE criteria for all the three parameters. But as we all know that USFDA don’t encourage the outliers test and its exclusion from the study.

❝ […] The only option is if we remove the AUCt and AUCinf from the from two subjects whose %AUCextrap value is more than 20% and keeping Cmax and Tmax untouched. Our study qualifies the BE criteria of 80-125%.


Some points:

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
124 visitors (0 registered, 124 guests [including 17 identified bots]).
Forum time: 12:08 CEST (Europe/Vienna)

The great tragedy of Science – the slaying
of a beautiful hypothesis by an ugly fact.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5